Have HIV-associated neurological disorders declined in people with HIV due to recent antiretrovirals?
Further evidence that recycling tenofovir in second-line treatment is effective
Infant weight and height lower with efavirenz than with dolutegravir in pregnancy
Virtual approaches boost HIV self-testing in India
Nearly a third of babies with HIV given ART very soon after birth have no HIV antibodies two years later
Screening and early treatment reduce anal cancer risk by 57% in people living with HIV
Injected PrEP: cabotegravir maintains its advantage over four years
More focused HIV testing in PEPFAR countries yields results
New cases of hepatitis C declining in people with HIV as access to treatment broadens
